[Update on muscle relaxation : What comes after succinylcholine, rocuronium and sugammadex?]

[1]  T. Takazawa,et al.  Sugammadex and rocuronium-induced anaphylaxis , 2015, Journal of Anesthesia.

[2]  C. Ayata,et al.  Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents , 2015, Anesthesiology.

[3]  H. Sunaga,et al.  Novel neuromuscular blocking drugs and antagonists , 2015, Current opinion in anaesthesiology.

[4]  J. Sakles,et al.  Neuromuscular blockade improves first-attempt success for intubation in the intensive care unit. A propensity matched analysis. , 2015, Annals of the American Thoracic Society.

[5]  H. Feußner,et al.  Neuromuscular blockade improves surgical conditions (NISCO) , 2015, Surgical Endoscopy.

[6]  B. Urban,et al.  Rocuronium und Sugammadex in der Notfallmedizin , 2014, Wiener klinisches Magazin.

[7]  C. Ayata,et al.  Calabadion: A New Agent to Reverse the Effects of Benzylisoquinoline and Steroidal Neuromuscular-blocking Agents , 2013, Anesthesiology.

[8]  Matthias Eikermann,et al.  Acyclic cucurbit[n]uril-type molecular containers bind neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo. , 2012, Angewandte Chemie.

[9]  H. Sunaga,et al.  Rapid Chemical Antagonism of Neuromuscular Blockade by l-Cysteine Adduction to and Inactivation of the Olefinic (Double-bonded) Isoquinolinium Diester Compounds Gantacurium (AV430A), CW 002, and CW 011 , 2010, Anesthesiology.

[10]  Edward J Yoon,et al.  Cysteine Reversal of the Novel Neuromuscular Blocking Drug CW002 in Dogs: Pharmacodynamics, Acute Cardiovascular Effects, and Preliminary Toxicology , 2010, Anesthesiology.

[11]  H. Sunaga,et al.  Pharmacodynamics and Cardiopulmonary Side Effects of CW002, a Cysteine-reversible Neuromuscular Blocking Drug in Dogs , 2010, Anesthesiology.

[12]  S. Brull,et al.  Update on neuromuscular pharmacology , 2009, Current opinion in anaesthesiology.

[13]  F. Pühringer,et al.  Sugammadex: Eine neue Ära in der Antagonisierung von Muskelrelaxanzien , 2009, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[14]  A. Bom,et al.  Preclinical pharmacology of sugammadex. , 2009, Journal of critical care.

[15]  T. Fuchs-Buder,et al.  Sugammadex , 2008, Der Anaesthesist.

[16]  M. Eikermann,et al.  Reversal of Profound, High-dose Rocuronium–induced Neuromuscular Blockade by Sugammadex at Two Different Time Points: An International, Multicenter, Randomized, Dose-finding, Safety Assessor–blinded, Phase II Trial , 2008, Anesthesiology.

[17]  J. Proost,et al.  Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study: Efficacy, Safety, and Pharmacokinetics , 2007, Anesthesiology.

[18]  P. White,et al.  Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine–Glycopyrrolate and Edrophonium–Atropine , 2007, Anesthesia and analgesia.

[19]  Sanjay S. Patel,et al.  Preclinical Pharmacology of GW280430A (AV430A) in the Rhesus Monkey and in the Cat: A Comparison with Mivacurium , 2004, Anesthesiology.

[20]  Sanjay S. Patel,et al.  Clinical Pharmacology of GW280430A in Humans , 2004, Anesthesiology.

[21]  S. Oja,et al.  Mechanisms of L-Cysteine Neurotoxicity , 2000, Neurochemical Research.

[22]  Sanjay S. Patel,et al.  Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys. , 2003, Journal of medicinal chemistry.

[23]  T. Fuchs-Buder,et al.  Laryngeal Morbidity and Quality of Tracheal Intubation: A Randomized Controlled Trial , 2003, Anesthesiology.

[24]  Mark Bradley,et al.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. , 2002, Angewandte Chemie.

[25]  G. Gronert.  Cardiac Arrest after Succinylcholine: Mortality Greater with Rhabdomyolysis Than Receptor Upregulation , 2001, Anesthesiology.

[26]  L. Firestone,et al.  Haemodynamic effects of rocuronium bromide in adult cardiac surgical patients , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[27]  M. Naguib,et al.  Adverse Effects of Neuromuscular Blockers and Their Antagonists , 1998, Middle East journal of anaesthesiology.

[28]  M. Stipanuk,et al.  Role of the transsulfuration pathway and of gamma-cystathionase activity in the formation of cysteine and sulfate from methionine in rat hepatocytes. , 1990, The Journal of nutrition.

[29]  S. Muravchick,et al.  Succinylcholine-Induced Fasciculations and Intragastric Pressure During Induction of Anesthesia , 1981 .

[30]  R. Miller,et al.  The Effect of Repeated Doses of Succinylcholine on Serum Potassium in Patients with Renal Failure , 1975, Anesthesia and analgesia.